Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
Key facts
- Who runs it
- University of Southern California
- Where
- Uganda and Zambia2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 800 people, planned
- Started
- 13 Sept 2023
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nicotine patch
- text messaging
- Record updated
- 13 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- -
Who cannot take part
- Visitor, not receiving continuous care at study site
- <18 years (underage of consent)
- Females who are pregnant, planning to get pregnant, or breastfeeding
- Not a current daily tobacco user
- Any physical, cognitive, or psychological disabilities that would prevent them from participating in the study
- Illiterate in English and/or local languages
- Does not consent
This trial is currently available in Uganda and Zambia.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This proposal tests the efficacy of a phone-based tobacco cessation intervention for people living with HIV (PLWH) in comparison to the standard of care (brief advice to quit) and nicotine replacement therapy (nicotine patches) in Uganda and Zambia. This study will provide insight into the efficacy, feasibility, applicability, and affordability of delivering tobacco cessation interventions through health care professionals at HIV treatment centers in two countries with different tobacco use patterns, policy environments, and health care resources. The previously tested SMS-platform to be used in this study is uniquely positioned to be scaled in low- and middle-income countries worldwide, in which case rigorous research showing even modest success in reducing the prevalence of tobacco consumption among PLWH could confer substantial health and economic benefits.
The 4 groups in the trial
- Standard of CareNo study treatment, for comparison
This is the baseline group receiving advice to quit.
- Nicotine ReplacementExisting treatment, for comparison
This group will receive the standard of care and be prescribed nicotine replacement therapy
Treatment: Nicotine patch
- Text MessagingExisting treatment, for comparison
This group will receive the standard of care and receive text message support
- Nicotine replacement and text messagingExisting treatment, for comparison
This group will receive the standard of care, be prescribed nicotine replacement therapy, and receive text message support
Treatment: Nicotine patch and text messaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia (Quit4Life+ )
- Publications
- Usability and cultural adaptation of a text message-based tobacco cessation intervention for people living with HIV in Uganda and Zambia.Addiction science & clinical practice, 2025
- Understanding stigma as a barrier to cancer prevention and treatment: a qualitative study among people living with HIV in Uganda and Zambia.BMJ open, 2025
- A phone-based tobacco use cessation program for people living with HIV in Uganda and Zambia: study protocol for a randomized controlled trial.Addiction science & clinical practice, 2024
- Record updated
- 13 November 2026